The earnings call highlighted strong growth in e-commerce and effective cost management, along with successful market share expansion in the dental category. However, challenges with Clear Eyes supply constraints and declining revenue due to lower sales in key categories were noted. Investment in marketing and strategic acquisitions are expected to support future growth.
Company Guidance
During the Q2 2026 earnings call, Prestige Consumer Healthcare, Inc. provided guidance for the fiscal year, projecting revenues between $1.1 billion and $1.115 billion, with an organic growth decline of approximately 1.5% to 3% compared to the prior year. The company expects Q3 revenue of approximately $282 million, down from the prior year due to Clear Eyes inventory receipt timing and adjustments in e-commerce retailer orders. Adjusted EPS for the full year is anticipated to be between $4.54 and $4.58, at the higher end due to share repurchase efforts, with a Q3 expectation of $1.14. Prestige continues to expect a gross margin of 56.5% for the year and aims to generate free cash flow of $245 million or more. The company also plans to close the $100 million acquisition of eye care manufacturer Pillar5 in Q3. The guidance reflects ongoing improvements in Clear Eyes supply and expected sequential revenue improvements in the second half, despite macroeconomic challenges and variability in e-commerce order patterns.
E-commerce Growth
Double-digit e-commerce consumption growth was observed, driven by long-term investments. The company has maintained strong performance during large-scale e-commerce sales events.
Free Cash Flow Increase
The company generated $133.6 million in free cash flow for the first half, up approximately 10% versus the prior year.
DenTek Market Share Expansion
DenTek's market share increased by over 5 percentage points, with the brand now holding more than 50% of the dental guards category.
Share Repurchase
1.6 million shares were repurchased for approximately $110 million, helping to drive EPS forecasts to the higher end of the prior range.
Prestige Consumer Healthcare (PBH) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
PBH Earnings-Related Price Changes
Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 06, 2025
$59.83
$61.36
+2.56%
Aug 07, 2025
$75.16
$67.61
-10.05%
May 08, 2025
$81.41
$87.04
+6.92%
Feb 06, 2025
$76.10
$87.35
+14.78%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Prestige Consumer Healthcare (PBH) report earnings?
Prestige Consumer Healthcare (PBH) is schdueled to report earning on Feb 05, 2026, Before Open (Confirmed).
What is Prestige Consumer Healthcare (PBH) earnings time?
Prestige Consumer Healthcare (PBH) earnings time is at Feb 05, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.